The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

NIH launches $280m genome-sequencing project

25 January 2016
Appeared in BioNews 836

The US National Institutes of Health (NIH) has pledged over US$280 million over the next four years to genome sequencing targeting common and rare human diseases.

Providing grants totalling US$240 million, the NIH's National Human Genome Research Institute (NHGRI) has launched a large-scale collborative project coordinated by the Centers for Common Disease Genomics (CCDG), which will set up a network of sequencing and analysis centres to conduct research into the genetic basis of common conditions such as heart disease, stroke and diabetes. Additional funding is being provided by the National Heart, Lung, and Blood Institute (NHLBI).

The project plans to sequence 150,000 to 200,000 genomes from people affected by a range of common diseases in an attempt to understand how genetics can influence disease risk. The investigators will initially focus on cardiovascular and mental disorders that affect the nervous system, but may expand to autoimmune and bone diseases, as well as Alzheimer's disease.

'The center investigators plan to use genome sequencing to identify as many of the genes and genomic variants underlying common diseases as possible,' said Dr Adam Felsenfeld, director of the NHGRI Genome Sequencing Program. 'Building on existing research, they will continue to uncover new biological insights into the development of common disease.'

At the McDonnell Genome Institute at the University of Washington, researchers plan to sequence 40,000 genomes from diverse ethnicities. Building on its current profile of 20,000 samples from a distinctive Finnish population and thousands of genomes from African-Americans, it hopes to identify genetic variants involved in diabetes and heart disease.

Dr Rick Wilson, director of the McDonnell Genome Institute, commented:  'If we can identify these genes, we might be able to create new drugs and identify people who are at risk way before they would ever have a heart attack.'

A number of institutions, including the Broad Institute, Johns Hopkins University and the Baylor College of Medicine, have also been provided with US$40 million worth of grant funding over four years through the Centers for Mendelian Genomics (CMG) to support ongoing research into rare and typically single-gene conditions, such as muscular dystrophy and cystic fibrosis. Additional funding has also been pledged by the NHLBI and the National Eye Institute.

'Rare diseases provide an important window into the biology of both rare and common diseases,' said Dr Lu Wang, director of the CMG program, which was started in 22053.

Meanwhile, the 100,000 Genomes Project in the UK has started to recruit its first cancer patients. By sequencing the patient's genome and DNA from their tumours, the researchers hope to gain a better understanding of disease risk and the responsiveness of cancer treatment.

The £300 million project aims to map, sequence and analyse 100,000 genomes from cancer patients, as well as from people with rare conditions and their families by 2017. Over 6000 genomes have been sequenced so far.

31 July 2017 - by Dr Molly Godfrey 
A comprehensive map of genes crucial to tumour cell survival has been created by researchers...
10 July 2017 - by Dr Rachel Brown 
A packed public event, produced by the Progress Educational Trust in partnership with Genomics England, saw the Chief Medical Officer for England launch her report 'Generation Genome'...
26 September 2016 - by Ayala Ochert 
China has opened a national gene bank that could ultimately be the world's biggest, eventually housing 300 million genetic samples...
20 June 2016 - by Rikita Patel 
Genomics could help predict drug side effects in patients with type 2 diabetes early in the drug development process, according to a study...
13 June 2016 - by Kulraj Singh Bhangra 
The US National Institutes of Health has announced a new initiative that encourages the sharing of genomic and clinical data among researchers across the world...
18 April 2016 - by Elie Diner 
Scientists searching through nearly 600,000 genome sequences have found 13 'superhumans' who are symptom-free despite carrying mutations for severe childhood diseases...
15 February 2016 - by Kulraj Singh Bhangra 
US start-up company Sure Genomics has launched the first whole-genome testing service available directly to consumers, for a cost of $2500...
18 January 2016 - by Dr Molly Godfrey 
Two girls have become the first children to be diagnosed with rare genetic conditions through the 100,000 Genomes Project – the NHS DNA-sequencing initiative...
16 March 2015 - by Hannah Somers 
Three British men have been diagnosed with rare diseases after having their complete genomes sequenced as part of the UK-based 100,000 Genomes Project...
2 March 2015 - by Alice Hazelton 
Genome sequencing offers great potential for the effective diagnosis and future treatment of many conditions. But while the excitement continues to grow around the science, few have stopped to ask what patients, the ultimate end-beneficiaries of this technology, think...
18 November 2014 - by Dr Sarah Wynn 
The 100,000 Genomes Project aims to sequence 100,000 genomes by 2017. A proportion of these genomes will be from patients who have an undiagnosed rare disease. This project has the potential to make a dramatic impact on the numbers of people receiving a much-needed diagnosis for themselves or their child...
10 November 2014 - by Dr Simon Woods 
The 100,000 Genomes Project is raising some thorny ethical issues: what kind of feedback should research participants receive, and how?...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.